fbpx

Lung Cancer

The standard set

The ICHOM Standard Set for Lung Cancer is the result of hard work by a group of leading physicians, measurement experts and patients. It is our recommendation of the outcomes that matter most to patients with Lung Cancer. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients.

1 Includes major surgical complications, major radiation complications, and major systemic therapy complications. Recorded via the Common Terminology Criteria for Adverse Events (CTCAE), version 4.0

2 Recorded via the Eastern Cooperative Oncology Group (ECOG) score

3 Recommended to track via the European Organization for Research and Treatment of Cancer Quality of Life Lung Cancer-Specific Questionnaire (EORTC QLQ-LC13)

4 Recommended to track via the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)

5 Includes physical, emotional, cognitive, and social function and well-being 6 Includes treatment-related mortality and cause of death

6 Includes treatment related mortality and cause of death

Download the flyer

A brief overview of the most important outcomes for patients relating to this ICHOM Standard Set.

Reference Guide

A complete overview of the ICHOM Standard Set, including definitions for each measure and selected PROM instruments, time points for collection, and associated risk factors.

Data Dictionary

An index of the outcomes and case-mix variables included in the standard set, how to code them, and the information you need to collect when implementing the outcomes in practice.

Team that developed this standard

Australia

Robert Stirling | Monash University

Belgium

Jan van Meerbeeck | Antwerp University Hospital

Brazil

Clarissa Baldatto | Clínicas Oncológicas Integradas

Netherlands

Franz Schramel | St. Antonius Hospital
Suresh Senan | VU University Medical Centre Amsterdam
Michel Wouters | Netherlands Cancer Institute

United Kingdom

Matthew Baker*
David Baldwin | Nottingham University Hospitals
Diana Borthwick | Edinburgh Cancer Research Centre
Jesme Fox | Roy Castle Lung Cancer Foundation
Tom Haswell*
Mick Peake | University Hospital Leicester

United States

Janet Abrahm | Dana-Farber Cancer Institute
David Carbone | Ohio State University Comprehensive Cancer Center
Aileen Chen | Dana-Farber Cancer Institute
Marianna Koczywas | City of Hope National Medical Center
Benjamin Kozower | University of Virginia Health System
Kimberley Mak | Dana-Farber Cancer Institute
Reza Mehran | MD Anderson Cancer Center

* Parent representative

Stay up to date

To receive updates about new versions and opportunities to implement this standard set, please submit your details below

View more standard sets

Diabetes

Diabetes, blood, and endocrine

Paediatric Facial Palsy

Congenital anomalies

Congenital Upper Limb Anomalies

Congenital anomalies

Inflammatory Arthritis

Musculoskeletal

TOP